The e-vapor industry is rapidly growing around the world, with global sales in 2016 expected to exceed $4 billion. The global regulatory environment for these products is rapidly evolving, particularly in the United States. With recent announcements by the Food and Drug Administration that brings forward tailored laws and regulations that attempt to understand the public health and safety concerns presented by these novel products.
The Food and Drug Administration’s action, which represents the first time the government has regulated the booming market of e-cigarettes, seeks to clamp down on devices that have become increasingly popular, especially among young people, even as they have been subject to almost no oversight. The new rules issued will also extend to long-standing restrictions on traditional cigarettes to a host of other products, including e-cigarettes, hookah tobacco, pipe tobacco and nicotine gels. Minors would be banned from buying the products.
The session will review the legal status of these e-vapor products in the United States, with a focus on the impact of the new FDA rules implemented by the United States Food and Drug Administration (FDA), which propose to treat e-cigarettes and their components, including e-liquid, as tobacco products. Join Mr. Azim Chowdhury in a discussion on how FDA’s proposed rule will substantially change the way e-vapor products are currently manufactured, marketed and distributed in the United States, as well as its potential impact on the global market.
Why Should You Attend:
FDA recently released proposed regulations that would bring tobacco products not currently regulated by the FDA under the control of the Tobacco Control Act (the so-called ‘Deeming Regulations’). This rule will substantially change the way e-cigarettes, cigars, and other tobacco products are currently manufactured, marketed and distributed.
This 60-minute webinar will focus on key points of the Deeming Regulations, discuss the provisions of the rule on which the FDA requested public comment, discuss the potential public health impact and explore the varying stakeholder perspectives. It is critical for manufacturers and importers of cigars, pipe tobacco, electronic cigarettes, dissolvable tobacco and other novel tobacco products to be prepared to comment on Deeming Regulation.
This program, will take you through:
You will also get answers to the following tough questions:
Who should attend?
- Dr. David Lim
Azim Chowdhury is a Partner at Keller and Heckman LLP based in Washington, DC. Mr. Chowdhury advises domestic and foreign corporations in matters of FDA and international regulatory compliance. In particular, he assists corporations in establishing clearances for food and drug additives, and is a nationally recognized expert on tobacco and e-vapor product regulation relating to the implementation of...
More Events By The Speaker